Literature DB >> 17973543

Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.

Marta Irujo1, Guadalupe Beitia, Maira Bes-Rastrollo, Adolfo Figueiras, Sonia Hernández-Díaz, Berta Lasheras.   

Abstract

BACKGROUND: The spontaneous reporting system is the most efficient warning system of adverse drug reactions (ADRs). Pharmacists can play an important role in the detection and reporting of ADRs. The factors that affect under-reporting among these professionals are unknown in Spain.
OBJECTIVE: To identify the factors that influence community pharmacists' ADR under-reporting in Navarra, a Northern Spanish region.
METHODS: A case-control study was conducted on a population of 802 community pharmacists working in Navarra. Cases were pharmacists who had reported at least two ADRs to the region's drug surveillance unit between 2003 and 2005 and who agreed to participate in the study (18/20; 90%). A random sample of 60 controls was selected from the 762 pharmacists who had not reported any ADR during the same period of time.
RESULTS: Factors positively associated with ADR reporting were age, years of work experience as a pharmacist, participation in educational activities related to the detection and resolution of drug-related problems, the habit of detecting ADRs as part of pharmacists' duties, having the basic knowledge needed to report ADRs, and disagreement with the common belief among healthcare professionals that 'to report an ADR it is necessary to be sure that the reaction is related to the use of a particular drug'. The most frequently mentioned reasons for not reporting ADRs were the ADR is not serious, the ADR is already known, uncertainty concerning the causal relationship between the ADR and the drug, forgetting to report the ADR and a lack of time.
CONCLUSIONS: Pharmacists' knowledge, beliefs, behaviour and motivation play an important role in ADR reporting. Under-reporting might be improved through activities focused on modifying such factors.

Entities:  

Mesh:

Year:  2007        PMID: 17973543     DOI: 10.2165/00002018-200730110-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  33 in total

1.  Physicians' attitudes towards voluntary reporting of adverse drug events.

Authors:  A Figueiras; F Tato; J Fontaiñas; B Takkouche; J J Gestal-Otero
Journal:  J Eval Clin Pract       Date:  2001-11       Impact factor: 2.431

Review 2.  Pharmacovigilance of herbal medicines : a UK perspective.

Authors:  Joanne Barnes
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA.

Authors:  S R Ahmad; J P Freiman; D J Graham; R C Nelson
Journal:  Pharmacoepidemiol Drug Saf       Date:  1996-01       Impact factor: 2.890

Review 4.  Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.

Authors:  María T Herdeiro; Jorge Polonia; Juan J Gestal-Otero; Adolfo Figueiras
Journal:  J Eval Clin Pract       Date:  2004-11       Impact factor: 2.431

5.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

6.  An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

Authors:  Adolfo Figueiras; Maria T Herdeiro; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

7.  Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.

Authors:  Ane Gedde-Dahl; Pernille Harg; Hanne Stenberg-Nilsen; Marit Buajordet; Anne Gerd Granas; Anne Marie Horn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-09       Impact factor: 2.890

8.  Attitudes to adverse drug reaction reporting.

Authors:  W H Inman
Journal:  Br J Clin Pharmacol       Date:  1996-05       Impact factor: 4.335

9.  The role of pharmacists in adverse drug reaction reporting.

Authors:  P I Roberts; D J Wolfson; T G Booth
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

10.  [Adverse drug reactions and a program of voluntary notification: an opinion survey of primary care physicians].

Authors:  G Serrano Cózar; C Esteban Calvo; J A Gijón Porta; I Vaquero Turiño; M I Vázquez Burgos; C Ibáñez Ruiz; J Frías Iniesta
Journal:  Aten Primaria       Date:  1997-04-15       Impact factor: 1.137

View more
  36 in total

1.  Texas pharmacists' opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study.

Authors:  Paul Gavaza; Carolyn M Brown; Star Khoza
Journal:  Pharm World Sci       Date:  2010-07-23

2.  Knowledge, practices and attitudes towards adverse drug reaction reporting by private practitioners from klang valley in malaysia.

Authors:  Renu Agarwal; Aqil Mohammad Daher; Nafeeza Mohd Ismail
Journal:  Malays J Med Sci       Date:  2013-03

3.  Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.

Authors:  Paul Gavaza; Carolyn M Brown; Kenneth A Lawson; Karen L Rascati; James P Wilson; Mary Steinhardt
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

4.  Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities.

Authors:  Ramadan Mohamed Elkalmi; Mohamed Azmi Hassali; Mohamed Izham M Ibrahim; Riyanto T Widodo; Qais M A Efan; Muhammad Abdul Hadi
Journal:  Am J Pharm Educ       Date:  2011-06-10       Impact factor: 2.047

5.  Factors that affect adverse drug reaction reporting among hospital pharmacists in Western China.

Authors:  Jun Liu; Zhongliang Zhou; Shimin Yang; Bianling Feng; Jun Zhao; Hua Liu; Haiyan Huang; Yu Fang
Journal:  Int J Clin Pharm       Date:  2015-04-02

6.  Knowledge, Attitudes, and Practices of Health Care Professionals Toward Adverse Drug Reaction Reporting in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia: A Cross-sectional Study.

Authors:  Hussen Shanko; Jemal Abdela
Journal:  Hosp Pharm       Date:  2017-10-25

7.  Effect of Educational Interventions on Adverse Drug Reaction Reporting in a Cancer Institute in Japan: A Questionnaire Study.

Authors:  Masami Tsuchiya; Akihisa Esashi; Taku Obara; Kyoko Inooka; Nariyasu Mano; Chizuko Takamura
Journal:  Hosp Pharm       Date:  2018-04-13

8.  Pharmacovigilance: empowering healthcare professionals and patients.

Authors:  Stephane Steurbaut; Yolande Hanssens
Journal:  Int J Clin Pharm       Date:  2014-09-05

9.  Detection of adverse drug reactions through the minimum basic data set.

Authors:  Antonio Salmerón-García; José Cabeza Barrera; Maria José Vergara Pavón; Eva Román Márquez; Sol Cortés de Miguel; Inmaculada Vallejo-Rodríguez; Susana Raya García; Emilia Casado Fernández
Journal:  Pharm World Sci       Date:  2010-03-06

10.  Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.

Authors:  Mireille Gony; Kattalin Badie; Agnès Sommet; Julien Jacquot; Dominique Baudrin; Pierre Gauthier; Jean Louis Montastruc; Haleh Bagheri
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.